As of 2024-12-12, the Fair Value of Aerie Pharmaceuticals Inc (AERI) is -3.70 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 15.25 USD, the upside of Aerie Pharmaceuticals Inc is -124.25%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | -145.11 | -232.57 | -199.58 | -183.10 | -74.81 | -167.03 |
| YoY growth | -46.49% | -60.27% | 14.18% | 8.26% | 59.14% | -5.03% |
| Market Cap (mil) | 753.62 |
| P/E | |
| Forward P/E |
| EPS | -0.74 |
| Avg earnings growth rate | -5.03% |
| TTM earnings | -36.56 |